Patents by Inventor Bernard E. Cabana

Bernard E. Cabana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8629302
    Abstract: The present invention provides a method for making hypericin comprising the steps of converting a protohypericin to a protohypericin salt, and irradiating the protohypericin salt with visible light to form hypericin. The present invention also provides an apparatus comprising a transparent column having a top end and a bottom end, an inlet attached to the column at the top end to flow reactants into the column, a container attached to the column at the bottom end; and a visible light source positioned to cast light on to the column. The present invention further provides a method for making hypericin using said apparatus.
    Type: Grant
    Filed: September 15, 2010
    Date of Patent: January 14, 2014
    Inventors: Alfonso J. Tobia, Bernard E. Cabana, Venkata Vadlapatla, Ronald H. Connolly
  • Publication number: 20130211371
    Abstract: A liquid or ointment formulation for the treatment of a skin condition associated with leukocyte accumulation in the skin includes a therapeutic compound selected to reduce leukocyte accumulation in the skin and an aqueous solution of an organic solvent. The organic solvent increases skin permeability. A method of treating a skin condition associated with leukocyte accumulation in the skin includes the steps of applying topically a liquid formulation of a photosensitizer to a skin lesion of a patient afflicted with the skin condition and exposing the skin lesion to a light source.
    Type: Application
    Filed: April 20, 2011
    Publication date: August 15, 2013
    Applicant: Hy Biopharma, Inc.
    Inventors: Alfonso J. Tobia, Bernard E. Cabana, Alain H. Rook
  • Publication number: 20120245392
    Abstract: The present invention provides a method for making hypericin comprising the steps of converting a protohypericin to a protohypericin salt, and irradiating the protohypericin salt with visible light to form hypericin. The present invention also provides an apparatus comprising a transparent column having a top end and a bottom end, an inlet attached to the column at the top end to flow reactants into the column, a container attached to the column at the bottom end; and a visible light source positioned to cast light on to the column. The present invention further provides a method for making hypericin using said apparatus.
    Type: Application
    Filed: September 15, 2010
    Publication date: September 27, 2012
    Applicant: HY BIOPHARMA, INC
    Inventors: Alfonso J. Tobia, Bernard E. Cabana, Venkata Vadlapatla, Ronald H. Connolly
  • Publication number: 20120046281
    Abstract: The invention features low-dosage rifalazil compositions and therapeutic regimens which are useful for the treatment of bacterial infections.
    Type: Application
    Filed: October 31, 2011
    Publication date: February 23, 2012
    Applicant: ACTIVBIOTICS PHARMA, LLC.
    Inventors: Bernard E. Cabana, Arthur F. Michaelis, Gary P. Magnant, Chalom B. Sayada
  • Patent number: 8097607
    Abstract: The invention features low-dosage rifalazil compositions which are useful for the treatment of bacterial infections.
    Type: Grant
    Filed: September 23, 2003
    Date of Patent: January 17, 2012
    Inventors: Bernard E. Cabana, Arthur F. Michaelis, Gary P. Magnant, Chalom B. Sayada
  • Patent number: 7820652
    Abstract: The invention features an ascending dose regimen for the administration of rifamycin-class antibiotics. The dosing regimen can be used to treat bacterial infections and diseases related to infection.
    Type: Grant
    Filed: September 23, 2004
    Date of Patent: October 26, 2010
    Assignee: ActivBiotics Pharma, LLC
    Inventors: Arthur F. Michaelis, Bernard E. Cabana
  • Publication number: 20040157840
    Abstract: The invention features low-dosage rifalazil compositions and therapeutic regimens which are useful for the treatment of bacterial infections.
    Type: Application
    Filed: September 23, 2003
    Publication date: August 12, 2004
    Inventors: Bernard E. Cabana, Arthur F. Michaelis, Gary P. Magnant, Chalom B. Sayada
  • Publication number: 20040034021
    Abstract: The invention features intravenous dosage formulations of rifalazil and methods of treating disease by intravenous administration of rifalazil.
    Type: Application
    Filed: June 3, 2003
    Publication date: February 19, 2004
    Inventors: Arthur F. Michaelis, Chalom Sayada, Bernard E. Cabana